Stay updated on Ipilimumab Nivolumab Combo in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added Melanoma label and related topics (MedlinePlus Genetics). Site revision updated to v3.5.0, replacing v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-19T05:17:05.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added and v3.4.2 removed.
    Difference
    0.1%
    Check dated 2026-03-11T23:27:47.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The study page no longer lists Melanoma as the primary condition, and the 'MedlinePlus Genetics' related topics section has been removed.
    Difference
    0.2%
    Check dated 2026-03-04T23:11:55.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the government funding operating-status banner. Core study content, including eligibility criteria, interventions, and outcomes, remains unchanged.
    Difference
    0.4%
    Check dated 2026-02-11T14:07:14.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and current operating status. Updated the page revision to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T10:26:05.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    UI/metadata updates include adding glossary display, melanoma as a related topic, MedlinePlus Genetics, and a new revision tag (v3.4.0), replacing older QC-related labels. The old labels Last Update Submitted that met QC Criteria, No FEAR Act data, and v3.3.4 were removed.
    Difference
    0.4%
    Check dated 2026-01-28T05:56:11.000Z thumbnail image

Stay in the know with updates to Ipilimumab Nivolumab Combo in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Combo in Melanoma Clinical Trial page.